Brief: Sana Biotechnology Q1 net loss USD 82.123 million
08/05/2023 22:07
May 8 (Reuters) - Sana Biotechnology Q1 operating expenses USD 84.052 million. * Q1 net income USD -82.123 million * Q1 EPS USD -0.43
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17